Penicillin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product (Bulk, Dosage), By Type (Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, Others), By Route of Administration (Oral, Intramuscular, Intravenous), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions), By Region and Competition

April 2023 | 119 pages | ID: P138AED326FFEN
TechSci Research

Abstracts

The global penicillin market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the high prevalence of infectious diseases such as lower respiratory infections, malaria, and tuberculosis, among others. In 2020, Africa had the highest prevalence of tuberculosis incidence per 100 000 population. The incidence rate was about 220. Similarly, the Americas reported some 29 new cases of tuberculosis per 100,000 inhabitants. Additionally, growing initiatives and investments by government organizations and pharmaceutical & biotechnology companies across the globe for developing novel antibiotics have significantly increased the demand for penicillin worldwide. Additionally, the growing adoption of new drugs in the healthcare sector has significantly increased, thereby supporting the growth of global penicillin market. Besides, increasing awareness about novel treatments will further increase the demand for penicillin in the coming years, thereby supporting market growth.

Growing Prevalence of Various Types of Infections

Every day the frequency of bacterial infections is increasing. The main reason for increasing bacterial infection is not maintaining proper health, not washing hands before eating or cooking, sneezing without covering, and poor sanitation and hygiene practices. This has significantly increased the demand for antibiotics, thereby creating lucrative growth opportunities for the penicillin market during the forecast period. In 2021, the daily defined dose of antibiotics consumption in Italy was around 13 per 1,000 inhabitants. Similarly, in low and middle-income countries, public transport is the main source of communication, and most of the spread of bacterial infections is being witnessed due to the use of public transport, thereby increasing the demand for antibiotics and creating opportunities for the growth of the penicillin market.

Expanding Research & Development Activities

The growing incidence of antibiotic resistance in bacteria and the increasing prevalence of various communicable bacterial infections have made biotechnology and pharmaceutical companies focus on developing new and advanced therapies and products. This, in turn, is expected to create new prospects for the growth of the penicillin market. According to clinicaltrials.gov, there are around 93 clinical trials related to penicillin that are under different phases. Similarly, betterment in the new drug approval process is expected to boost market growth over the years. In 2020, Merck received an acceptance for a review of a supplemental new drug application from the U.S. FDA for RECARBRIO intended for HABP/VABP. The growing burden of infectious diseases is compelling government and non-government organizations to invest in research and development activities that will further boost the development of novel antibiotics and create new policies for the development of new drugs.

Market Segmentation

The global penicillin market can be segmented by product, type, route of administration, end-user, and by region. Based on the product, the market can be divided into Bulk and Dosage. Based on type, the market can be segmented into Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, and Others. Based on the route of administration, the market can be differentiated into Oral, Intramuscular, and Intravenous. Based on end users, the market can be grouped into Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutions. Regionally, North America dominated the market among Asia Pacific, Europe, the Middle East & Africa, and South America. Among the different countries, the United States dominated the global penicillin market on account of the increasing prevalence of infectious in the country. According to the Centers for Disease Control and Prevention, the number of visits to physician offices for infectious and parasitic diseases is around 7.2 million.

Recent Development

• In August 2022, PAION AG launched XERAVA (eravacycline), in Germany, for the treatment of complicated intra-abdominal infections (cIAI) in adults.
• In October 2021, the Cephalosporin antibiotics branch of GSK was purchased by Novartis. It is currently the exclusive owner of three well-known brands in more than 100 markets, establishing its position as the top manufacturer of antibiotics across the globe.

Market Players

Astellas Pharma Inc., Novartis International AG, GlaxoSmithKline plc, Pfizer Inc., Merck Co. & Inc., F.Hoffmann-La Roche Ltd., Toyama Chemical Co., Ltd., Sanofi Aventis SA, MiddleBrook Pharmaceuticals, Inc., Gilead Sciences Inc. are some of the leading players operating in the Global Penicillin Market.

Report Scope:

In this report, global penicillin market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

• Penicillin Market, By Product:
• Bulk
• Dosage
• Penicillin Market, By Type:
• Aminopenicillin
• Antipseudomonal Penicillin
• Beta Lactamase Inhibitor
• Others
• Penicillin Market, By Route of Administration:
• Oral
• Intramuscular
• Intravenous
• Penicillin Market, By Route of End User:
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Penicillin Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Penicillin Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

1.1. Market Definition
1.2. Scope of the Market
  1.2.1. Markets Covered
  1.2.2. Years Considered for Study
  1.2.3. Key Market Segmentations

2. RESEARCH METHODOLOGY

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. EXECUTIVE SUMMARY

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. VOICE OF CUSTOMER

5. CLINICAL TRIAL ANALYSIS

5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Type
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map

6. GLOBAL PENICILLIN MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value & Volume
6.2. Market Share & Forecast
  6.2.1. By Product (Bulk, Dosage)
  6.2.2. By Type (Aminopenicillin, Antipseudomonal Penicillin, Beta Lactamase Inhibitor, Others)
  6.2.3. By Route of Administration (Oral, Intramuscular, Intravenous)
  6.2.4. By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutions)
  6.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  6.2.6. By Company (2022)
6.3. Market Map
  6.3.1. By Product
  6.3.2. By Application
  6.3.3. By Technique
  6.3.4. By Source
  6.3.5. By Region

7. NORTH AMERICA PENICILLIN MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value & Volume
7.2. Market Share & Forecast
  7.2.1. By Product
  7.2.2. By Type
  7.2.3. By Route of Administration
  7.2.4. By End User
  7.2.5. By Country
7.3. North America: Country Analysis
  7.3.1. United States Penicillin Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value & Volume
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Product
      7.3.1.2.2. By Type
      7.3.1.2.3. By Route of Administration
      7.3.1.2.4. By End User
  7.3.2. Canada Penicillin Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value & Volume
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Product
      7.3.2.2.2. By Type
      7.3.2.2.3. By Route of Administration
      7.3.2.2.4. By End User
  7.3.3. Mexico Penicillin Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value & Volume
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Product
      7.3.3.2.2. By Type
      7.3.3.2.3. By Route of Administration
      7.3.3.2.4. By End User

8. EUROPE PENICILLIN MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value & Volume
8.2. Market Share & Forecast
  8.2.1. By Product
  8.2.2. By Type
  8.2.3. By Route of Administration
  8.2.4. By End User
  8.2.5. By Country
8.3. Europe: Country Analysis
  8.3.1. France Penicillin Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value & Volume
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Product
      8.3.1.2.2. By Type
      8.3.1.2.3. By Route of Administration
      8.3.1.2.4. By End User
  8.3.2. Germany Penicillin Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value & Volume
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Product
      8.3.2.2.2. By Type
      8.3.2.2.3. By Route of Administration
      8.3.2.2.4. By End User
  8.3.3. United Kingdom Penicillin Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value & Volume
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Product
      8.3.3.2.2. By Type
      8.3.3.2.3. By Route of Administration
      8.3.3.2.4. By End User
  8.3.4. Italy Penicillin Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value & Volume
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Product
      8.3.4.2.2. By Type
      8.3.4.2.3. By Route of Administration
      8.3.4.2.4. By End User
  8.3.5. Spain Penicillin Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value & Volume
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Product
      8.3.5.2.2. By Type
      8.3.5.2.3. By Route of Administration
      8.3.5.2.4. By End User

9. ASIA-PACIFIC PENICILLIN MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value & Volume
9.2. Market Share & Forecast
  9.2.1. By Product
  9.2.2. By Type
  9.2.3. By Route of Administration
  9.2.4. By End User
  9.2.5. By Country
9.3. Asia-Pacific: Country Analysis
  9.3.1. China Penicillin Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value & Volume
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Product
      9.3.1.2.2. By Type
      9.3.1.2.3. By Route of Administration
      9.3.1.2.4. By End User
  9.3.2. India Penicillin Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value & Volume
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Product
      9.3.2.2.2. By Type
      9.3.2.2.3. By Route of Administration
      9.3.2.2.4. By End User
  9.3.3. Japan Penicillin Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value & Volume
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Product
      9.3.3.2.2. By Type
      9.3.3.2.3. By Route of Administration
      9.3.3.2.4. By End User
  9.3.4. South Korea Penicillin Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value & Volume
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Product
      9.3.4.2.2. By Type
      9.3.4.2.3. By Route of Administration
      9.3.4.2.4. By End User
  9.3.5. Australia Penicillin Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value & Volume
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Product
      9.3.5.2.2. By Type
      9.3.5.2.3. By Route of Administration
      9.3.5.2.4. By End User

10. SOUTH AMERICA PENICILLIN MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value & Volume
10.2. Market Share & Forecast
  10.2.1. By Product
  10.2.2. By Type
  10.2.3. By Route of Administration
  10.2.4. By End User
  10.2.5. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Penicillin Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value & Volume
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Product
      10.3.1.2.2. By Type
      10.3.1.2.3. By Route of Administration
      10.3.1.2.4. By End User
  10.3.2. Argentina Penicillin Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value & Volume
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Product
      10.3.2.2.2. By Type
      10.3.2.2.3. By Route of Administration
      10.3.2.2.4. By End User
  10.3.3. Colombia Penicillin Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value & Volume
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Product
      10.3.3.2.2. By Type
      10.3.3.2.3. By Route of Administration
      10.3.3.2.4. By End User

11. MIDDLE EAST AND AFRICA PENICILLIN MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value & Volume
11.2. Market Share & Forecast
  11.2.1. By Product
  11.2.2. By Type
  11.2.3. By Route of Administration
  11.2.4. By End User
  11.2.5. By Country
11.3. MEA: Country Analysis
  11.3.1. South Africa Penicillin Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value & Volume
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Product
      11.3.1.2.2. By Type
      11.3.1.2.3. By Route of Administration
      11.3.1.2.4. By End User
  11.3.2. Saudi Arabia Penicillin Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value & Volume
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Product
      11.3.2.2.2. By Type
      11.3.2.2.3. By Route of Administration
      11.3.2.2.4. By End User
  11.3.3. UAE Penicillin Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value & Volume
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Product
      11.3.3.2.2. By Type
      11.3.3.2.3. By Route of Administration
      11.3.3.2.4. By End User

12. MARKET DYNAMICS

12.1. Drivers
  12.1.1. Growing Prevalence of Infectious Diseases
  12.1.2. Rise in Research & Development Activities
  12.1.3. Supportive Government Policies & Initiatives
12.2. Challenges
  12.2.1. Development of Antibacterial Resistance
  12.2.2. Stringent Regulatory Scenario

13. MARKET TRENDS & DEVELOPMENTS

13.1. Recent Developments
13.2. Mergers & Acquisitions
13.3. Product Launches

14. GLOBAL PENICILLIN MARKET: SWOT ANALYSIS

15. COMPETITIVE LANDSCAPE

15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
  15.5.1. Astellas Pharma Inc.
  15.5.2. Novartis International AG
  15.5.3. GlaxoSmithKline plc
  15.5.4. Pfizer Inc.
  15.5.5. Merck Co. & Inc.
  15.5.6. F.Hoffmann-La Roche Ltd.
  15.5.7. Toyama Chemical Co., Ltd.
  15.5.8. Sanofi Aventis SA
  15.5.9. MiddleBrook Pharmaceuticals, Inc.
  15.5.10. Gilead Sciences Inc.

16. STRATEGIC RECOMMENDATIONS